CLIA Laboratory Citation Details
22D0861539
Survey Type: Standard
Survey Event ID: FR3F11
Deficiency Tags: D2006 D5293 D5391 D5779 D5791 D5891 D6063 D0000 D2000 D5209 D5311 D5400 D5403 D5413 D5415 D6046 D6065
Summary Statement of Deficiencies D0000 A federal surveyor from the Centers for Medicare & Medicaid Services (CMS) Survey Branch conducted an announced CLIA recertification survey at Tuffs University Nutrition Evaluation Laboratory from June 24, 2025 to June 25, 2025.. The laboratory was surveyed under 42 CFR part 493 CLIA regulations and found to not be in compliance with all condition-level CLIA requirements. The following condition and standard level deficiencies were found during CLIA recertification survey that concluded on June 25, 2025. D2000 ENROLLMENT AND TESTING OF SAMPLES CFR(s): 493.801 Each laboratory must enroll in a proficiency testing (PT) program that meets the criteria in subpart I of this part and is approved by HHS. The laboratory must enroll in an approved program or programs for each of the specialties and subspecialties for which it seeks certification. The laboratory must test the samples in the same manner as patients' specimens. For laboratories subject to 42 CFR part 493 published on March 14, 1990 (55 FR 9538) prior to September 1, 1992, the rules of this subpart are effective on September 1, 1992. For all other laboratories, the rules of this subpart are effective January 1, 1994. This CONDITION is not met as evidenced by: Based on the review of proficiency testing (PT) records and interview with the technical consultants (TC), the laboratory failed to examine PT samples in the same manner as patient samples for two out of two years from 2023 to 2025. Findings Included: Refer to D2006: D2006 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b) (b)The laboratory must examine or test, as applicable, the proficiency testing samples Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 9 -- it receives from the proficiency testing program in the same manner as it tests patient specimens. This testing must be conducted in conformance with paragraph (b)(4) of this section. If the laboratory's patient specimen testing procedures would normally require reflex, distributive, or confirmatory testing at another laboratory, the laboratory should test the proficiency testing sample as it would a patient specimen up until the point it would refer a patient specimen to a second laboratory for any form of further testing. This STANDARD is not met as evidenced by: Based on review of the College of American Pathologists (CAP) proficiency testing (PT) records, and interview with the technical consultant (TC), the laboratory failed to examine CAP PT samples it received in the same manner as it tests patient specimens for two of two years. Findings Included: 1. The Hematology Policy on repeating results states, "Results that do not fall within the ranges established by the nutrition evaluation lab are repeated. The repeat is in agreement with the initial result, the result closet to the normal range is reported. If both results are normal, the two results are averaged and then reported. 2. Review of patient test records on June 25, 2025 revealed, patient specimens are run in duplicate when they fell outside of established ranges. a. ID58442711 (11/27/2024) - ALP 115 / 115 - UA 2.8 / 3.9 b. ID58431034 (03/12/2025) - UA 4.3 / 4.3 3. Review of a sampling of the CAP Event 1 2025 - Hematology Automated Differential Series survey result forms, showed the following documented test run values for the below samples: a. FH10-1: 8.5, 8.5, 8.7, 8.8, 9.4 for WBC. b. FH10-2: 4.31, 4.31, 4.36, 4.41, 4.42 for RBC. c. FH10-3: 48.1, 49.0, 49.1, 49.4, 49.7 for HCT. d. FH10-4: 2.5, 2.5, 2.6, 2.6, 2.6 for WBC. e. FH10-5: 12.7, 12.7, 12.7, 12.7, 12.8 for HGB 3. By interview on June 25, 2025 at 12:20 pm, the TC confirmed they re-ran samples multiple time until they were close to there accepted range and that PT samples are not always run like patient samples. Key: RBC = Red Blood Cells. WBC = White Blood Cells. HCT = Hematocrit. HGB = Hemoglobin. D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on review of the training and evaluation policy, lack of technical consultant competency assessment records, and interview with the technical consultant, the laboratory failed establish a procedure to assess the competency for one of one TC delegated responsibilities in 2023 and 2024. Findings Included: 1. Review of the training and evaluation policy on June 24, 2025 at 10:00 am, revealed the policy did not include the assessment for TC for their delegated responsibilities. 2. Review of the TC's personnel folder on June 24, 2025 revealed, the TC was not assessed for competency of their delegated responsibilities in 2023 or 2024. 3. By interview, the TC confirmed on June 24, 2024 at 10:30 am their TC responsibilities were not assessed for competency is 2023 and 2024. D5293 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(b)(c) -- 2 of 9 -- (b) The general laboratory systems quality assessment must include a review of the effectiveness of
Get full access to the detailed deficiency summary for this facility
Survey Type: Standard
Survey Event ID: JDD411
Deficiency Tags: D6047 D2007 D5413 D5435
Summary Statement of Deficiencies D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on record review and interviews with Technical Consultant #1 (TC#1) and Technical Consultant #2 (TC#2), the laboratory failed to ensure proficiency testing samples were tested by all testing personnel identified on the laboratory personnel CMS 209 form for six of six proficiency testing events. Findings include: 1. Interview with TC#1 on 11/02/23 at 09:25 AM, confirmed the laboratory performed the following: a. Routine chemistry testing using the Beckman Coulter AU480 analyzer. b. Complete Blood Count (CBC) testing using the Horiba ABX Pentra 60+ analyzer. 2. Record review on 11/02/223 of the laboratory personnel CMS 209 form, completed by TC#1 prior to the survey, listed two testing persons (TP#1 and TP#2) performing the above testing. 3. Record review on 11/02/2023 of 2022 and 2023 proficiency testing records revealed that six of six events were tested by the same person (TP#1). 4. Interview with TC#2 on 11/02/2023 at 11:45 AM, confirmed the above findings. D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on observation, manufacturer's instructions, temperature records, humidity records, and interviews with Technical Consultant #1 (TC#1) and Technical Consultant #2 (TC#2), the laboratory failed to ensure the room temperature and humidity were maintained as required by the manufacturer for two of two analyzers for three of three months and failed to ensure blood collection tubes were stored according to manufacturer's instructions for three of three months. Findings include: A. Beckman Coulter AU480 analyzer 1. Interview with TC#1 on 11/02/23 at 09:25 AM, confirmed the laboratory performed the following: a. Routine chemistry testing using the Beckman Coulter AU480 analyzer. 2. Record review on 11/02/2023 of the manufacturer's environmental requirements titled, "2.3.1 System Specifications" (page 2-21) stated, "3. Operating environments" as follows: a. Temperature - 18 to 32C (Celsius) b. Humidity - 20 to 80% RH (Relative Humidity) 3. Record reviewon 11/02 /2023 of temperature records from August 2023 through October 2023, revealed no evidence of temperature or humidity monitoring for the Beckman Coulter AU480 analyzer for three of three months. 4. Interview with TC#2 on 11/02/23 at 02:30 PM, confirmed the findings above. B. Horiba ABX Pentra 60+ analyzer 1. Interview with TC#1 on 11/02/23 at 09:25 AM, confirmed the laboratory performed the following: a. Complete Blood Count (CBC) testing using the Horiba ABX Pentra 60+ analyzer. 2. Record review on 11/02/2023 of the manufacturer's environmental requirements titled, "2. PHYSICAL SPECIFICATIONS" stated, "2.2. Operating temperature and humidity" as follows: a. Temperature - 18 to 34C b. Humidity - Maximum relative humidity of 80% 3. Record review on 11/02/2023 of temperature records from August 2023 through October 2023, revealed no evidence of temperature or humidity monitoring for the Horiba ABX Pentra 60+ analyzer for three of three months. 4. Interview with TC#2 on 11/02/23 at 02:30 PM, confirmed the findings above. C. Blood Collection Tubes 1. Interview with TC#1 on 11/02/23 at 09:25 AM, confirmed the laboratory performed the following: a. Routine chemistry testing using the Beckman Coulter AU480 analyzer. b. Complete Blood Count (CBC) testing using the Horiba ABX Pentra 60+ analyzer. c. Blood collection tubes were stored in the nursing unit storage room. 2. Record review on 11/02/2023 of the manufacturer's environmental requirements for blood collection tubes on 11/02/2023, revealed a room temperature requirement between 4-25C. 3. Surveyor observation on 11/02 /2023 at 10:03 AM of blood collection tubes in the nursing storage room stored the following blood collection tubes: a. BD Vacutainer SST - 300 tubes of lot#3153030 b. BD Vacutainer K2 EDTA - 300 tubes of lot#2227128 4. Record review on 11/02/2023 of temperature records from August 2023 through October 2023, revealed no evidence of temperature monitoring for the blood collection tubes for three of three months. 5. Interview with TC#2 on 11/02/23 at 10:05 AM, confirmed the findings above. D5435 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(b)(2) For equipment, instruments, or test systems developed in-house, commercially available and modified by the laboratory, or maintenance and function check protocols are not provided by the manufacturer, the laboratory must: (i) Define a function check protocol that ensures equipment, instrument, and test system performance that is necessary for accurate and reliable test results and test result reporting. (ii) Perform and document the function checks, including background or baseline checks, specified in paragraph (b)(2)(i) of this section. Function checks must -- 2 of 3 -- be within the laboratory's established limits before patient testing is conducted. This STANDARD is not met as evidenced by: Based on record review of, written laboratory policy and procedure, and interviews with Technical Consultant #1 (TC#1) and Technical Consultant #2 (TC#2), the laboratory failed to follow their defined function check protocol to ensure the centrifuge was functioning properly for one of two preventative maintenance function checks. Findings include: 1. Interview with TC#1 on 11/02/23 at 09:25 AM, confirmed the laboratory performed the following: a. Routine chemistry testing using the Beckman Coulter AU480 analyzer. 2. Interview with TC#2 on 11/02/23 at 11:15 AM, confirmed the laboratory used the ThermoFisher Scientific Legend RT+ centrifuge to process chemistry testing. 3. Record review on 11/02/2023 of the written laboratory policy and procedure titled, "Policy for the Maintenance of the Laboratory Centrifuges" stated, "The Legend RT+ bench top ....will be serviced semi-annually for preventive maintenance and to ensure proper operation.". 4. Record review on 11/02 /23 of the preventive maintenance records from 06/06/2022 through the day of the survey (11/02/2023) revealed no evidence of preventative maintenance between 06/06 /2023 through 07/20/2023. 5. Interview with TC#1 and TC#2 on 11/02/2023 at 02:45 PM, confirmed the laboratory failed to ensure the centrifuge was functioning properly for one of two preventative maintenance checks. D6047 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b(8)(i) The procedures for evaluation of the competency of the staff must include, but are not limited to direct observations of routine patient test performance, including patient preparation, if applicable, specimen handling, processing and testing. This STANDARD is not met as evidenced by: Based on record review and interview with Technical Consultant #1 (TC#1), the technical consultant failed to ensure that evaluations included direct observation of patient test performance, including patient preparation, specimen handling, processing, and testing for two of two testing persons. Findings include: 1. Interview with TC#1 on 11/02/23 at 09:25 AM, confirmed the laboratory performed the following: a. Routine chemistry testing using the Beckman Coulter AU480 analyzer. b. Complete Blood Count (CBC) testing using the Horiba ABX Pentra 60+ analyzer. c. hCG serum pregnancy testing using the OSOM hCG test kit. 2. Record review on 11 /02/2023 of 2022 personnel records for two of two people performing the testing above, revealed no evidence that direct observation of patient test performance, including patient preparation, specimen handling, processing, and testing was included as part of the evaluation. 3. Interview with TC#1 on 11/23/2023 at 4:10 PM, confirmed the above findings. -- 3 of 3 --
Get full access to the detailed deficiency summary for this facility